Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 10, 2024 07:00 ET | Source: Crescendo Biologics

Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first ‘2 in 1’ immune cell engager CB699 at AACR 2024

Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first ‘2 in 1’ immune cell engager CB699 at AACR 2024 Preclinical data demonstrate strong rationale for...
March 06, 2024 07:00 ET | Source: Crescendo Biologics

Crescendo Biologics to present at the 2024 AACR Annual Meeting

Crescendo Biologics to present at the 2024 AACR Annual Meeting Cambridge, UK, 6 March 2024 – Crescendo Biologics Ltd (Crescendo), a clinical stage, immuno-oncology company developing novel, targeted...
January 10, 2022 08:00 ET | Source: BioNTech SE

BioNTech und Crescendo Biologics geben globale Kollaboration zur Entwicklung multispezifischer Präzisionsimmuntherapien bekannt

Die Zusammenarbeit kombiniert BioNTechs unternehmenseigene multimodulare Immuntherapie-Expertise mit Crescendos proprietärer Humabody® VH Plattform zur Entwicklung von Präzisionsimmuntherapien,...
January 10, 2022 08:00 ET | Source: BioNTech SE

BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies

Collaboration leverages BioNTech’s proprietary multimodal immunotherapy expertise with Crescendo’s proprietary Humabody® VH platform to develop precision immunotherapies, including mRNA-based...